Olfactory dysfunction as a diagnostic marker for Parkinson’s disease

References

• Ansari KA, Johnson A. Olfactory function in patients with Parkinson’s disease. J. Chron. Dis.28, 493–497 (1975).
   PubMedGoogle Scholar
• Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson’s disease. Neurology33, 943–946 (1983).
   PubMed Web of Science ®Google Scholar
• Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry62, 436–446 (1997).
   PubMed Web of Science ®Google Scholar
• Doty RL, Deems D, Steller S. Olfactory dysfunction in Parkinson’s disease: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology38, 1237–1244 (1988).
   PubMed Web of Science ®Google Scholar
• Haehner A, Boesveldt S, Berendse HW et al. Prevalence of smell loss in Parkinson’s disease – a multicenter study. Parkinsonism Relat. Disord.15, 490–494 (2009).
   PubMedGoogle Scholar
• Murphy C, Schubert CR, Cruickshanks KJ et al. Prevalence of olfactory impairment in older adults. JAMA288, 2307–2301 (2002).
   PubMed Web of Science ®Google Scholar
• Stern MB, Doty RL, Dotti M et al. Olfactory function in Parkinson’s disease subtypes. Neurology44, 266–268 (1994).
   PubMed Web of Science ®Google Scholar
• Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov. Disord.17, 867–876 (2002).
   PubMed Web of Science ®Google Scholar
• Hummel T. Olfactory evoked potentials as a tool to measure progression of Parkinson’s disease. In: Focus on Medicine – Vol. 14: New Developments in the Drug Therapy of Parkinson’s Disease. Chase T, Bedard P (Eds). Blackwell Science, Oxford, UK, 47–53 (1999).
   Google Scholar
• Tissingh G, Berendse HW, Bergmans P et al. Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov. Disord.16, 41–46 (2001).
   PubMed Web of Science ®Google Scholar
• Muller A, Mungersdorf M, Reichmann H, Strehle G, Hummel T. Olfactory function in Parkinsonian syndromes. J. Clin. Neurosci.9, 521–524 (2002).
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Studenski SA, Constantine GM, Moore RY. Diagnostic performance of clinical motor and non-motor tests of Parkinson’s disease: a matched case–control study. Eur. J. Neurol.15(7), 685–691 (2008).
   PubMedGoogle Scholar
• Hawkes CH, Shephard BC. Selective anosmia in Parkinson’s disease. Lancet341(8842), 435–436 (1993).
   PubMedGoogle Scholar
• Daum RF, Sekinger B, Kobal G, Lang CJG. Riechprüfung mit ‘sniffin’ sticks’ zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt71, 643–650 (2000).
   PubMed Web of Science ®Google Scholar
• Double KL, Rowe DB, Hayes M et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch. Neurol.60(4), 545–549 (2003).
   PubMed Web of Science ®Google Scholar
• Bohnen NI, Gedela S, Kuwabara H et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease J. Neurol.254(1), 84–90 (2007).
   PubMed Web of Science ®Google Scholar
• Witt M, Bormann K, Gudziol V et al. Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov. Disord.24(6), 906–914 (2009).
   PubMed Web of Science ®Google Scholar
• Müller A, Abolmaali ND, Hakimi AR et al. Olfactory bulb volumes in patients with Idiopathic Parkinson’s Disease – a pilot study. J. Neural Transm.112(10), 1363–1370 (2005).
   PubMedGoogle Scholar
• Huisman E, Uylings HB, Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov. Disord.19, 687–692 (2004).
   PubMedGoogle Scholar
• Winner B, Geyer M, Couillard-Despres S et al. Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol.197, 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Scherfler C, Schocke MF, Seppi K et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain129(Pt 2), 538–542 (2005).
   PubMedGoogle Scholar
• Westermann B, Wattendorf E, Schwerdtfeger U et al. Functional modulation of cortical olfactory pathways in Parkinson’s disease: an fMRI study. J. Neurol. Neurosurg. Psychiatry79, 19–24 (2008).
   PubMedGoogle Scholar
• Silveira-Moriyama L, Holton JL, Kingsbury A et al. Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci. Lett.453(2), 77–80 (2009).
   PubMed Web of Science ®Google Scholar
• Davidson TM, Freed C, Healy MP, Murphy C. Rapid clinical evaluation of anosmia in children: the alcohol sniff test. Ann. NY Acad. Sci.855, 787–792 (1998).
   PubMedGoogle Scholar
• Hummel T, Konnerth CG, Rosenheim K, Kobal G. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann. Otol. Rhinol. Laryngol.110, 976–981 (2001).
   PubMedGoogle Scholar
• Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. “Sniffin’ Sticks”: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem. Senses22, 39–52 (1997).
   PubMed Web of Science ®Google Scholar
• Kondo H, Matsuda T, Hashiba M, Baba S. A study of the relationship between the T&T olfactometer and the University of Pennsylvania smell identification test in a Japanese population. Am. J. Rhinol.12, 353–358 (1998).
   PubMedGoogle Scholar
• Larsson M, Nilsson LG, Olofsson JK, Nordin S. Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. Chem. Senses29, 547–554 (2004).
   PubMed Web of Science ®Google Scholar
• Ehrenstein WH, Ehrenstein A. Psychophysical methods. In: Modern Techniques in Neuroscience Research. Windhorst U, Johansson H (Eds). Springer, Berlin, Germany, 1211–1241 (1999).
   Google Scholar
• Lotsch J, Lange C, Hummel T. A simple and reliable method for clinical assessment of odor thresholds. Chem. Senses29, 311–317 (2004).
   PubMedGoogle Scholar
• Lötsch J, Reichmann H, Hummel T. Different odor tests contribute differently to the evaluation of olfactory loss. Chem. Senses33, 17–21 (2008).
   PubMed Web of Science ®Google Scholar
• Larsson M, Nilsson LG, Olofsson JK, Nordin S. Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. Chem. Senses29, 547–554 (2004).
   PubMed Web of Science ®Google Scholar
• Frasnelli J, Hummel T. Olfactory dysfunction and daily life. Eur. Arch. Otolaryngol.262, 231–235 (2005).
   PubMed Web of Science ®Google Scholar
• Hummel T, Kobal G. Olfactory event-related potentials. In: Methods and Frontiers in Chemosensory Research. Simon SA, Nicolelis MAL (Eds). CRC Press, FL, USA 429–464 (2001).
   Google Scholar
• Müller A, Reichmann H, Livermore A, Hummel T. Olfactory function in idiopathic Parkinson’s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J. Neural. Transm.109, 805–811 (2002).
   PubMed Web of Science ®Google Scholar
• Gonera EG, Van’t Hof M, Berger HJC, Van heel CD, Horstink MWIM. Symptoms and duration of the premotor phase in Parkinson’s disease. Mov. Disord.12, 871–876 (1997).
   PubMed Web of Science ®Google Scholar
• Tissingh G, Berendse HW, Bergmans P et al. Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov. Disord.16, 41–46 (2001).
   PubMed Web of Science ®Google Scholar
• Ponsen MM, Stoffers D, Booij J et al. Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann. Neurol.56, 173–181 (2004).
   PubMed Web of Science ®Google Scholar
• Ponsen MM, Stoffers D, Twisk JW, Wolters ECh, Berendse HW. Hyposmia and executive dysfunction as predictors of future Parkinson’s disease: a prospective study. Mov. Disord.24(7), 1060–1065 (2009).
   PubMed Web of Science ®Google Scholar
• Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov. Disord.22, 839–842 (2007).
   PubMed Web of Science ®Google Scholar
• Sommer U, Hummel T, Cormann K et al. Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord.19(10), 1196–1202 (2004).
   PubMed Web of Science ®Google Scholar
• Marras C, Goldman S, Smith A. Smell identification ability in twin pairs discordant for Parkinson’s disease. Mov. Disord.20, 687–693 (2005).
   PubMedGoogle Scholar
• Ross W, Petrovitch H, Abbott RD et al. Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann. Neurol.63, 167–173 (2008).
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging24, 197–211 (2003).
   PubMed Web of Science ®Google Scholar
• Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol. Scand.91, 247–250 (1995).
   PubMed Web of Science ®Google Scholar
• McKinnon JH, Demaerschalk BM, Caviness JN, Wellik KE, Adler CH, Wingerchuk DM. Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders? Neurologist13(6), 382–385 (2007).
   PubMedGoogle Scholar
• Liberini P, Parola S, Spano PF, Antonini L. Olfactory dysfunction in dementia associated with Lewy bodies. Parkinsonism Relat. Disord.5, 30 (1999).
   Google Scholar
• Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry80(6), 667–670 (2009).
   PubMed Web of Science ®Google Scholar
• Hawkes C. Olfaction in neurodegenerative disorder. Mov. Disord.18, 364–372 (2003).
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat. Disord.15(7), 516–520 (2009).
   PubMed Web of Science ®Google Scholar
• Katzenschlager R, Lees AJ. Olfaction and Parkinson’s syndromes: its role in differential diagnosis. Curr. Opin. Neurol.17(4), 417–423 (2004).
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Guedes LC, Kingsbury A et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology71(13), 1021–1026 (2008).
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Schwingenschuh P, O’Donnell A et al. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J. Neurol. Neurosurg. Psychiatry80(7), 744–748 (2009).
   PubMed Web of Science ®Google Scholar
• Doty RL, Singh A, Tetrud J, Langston JW. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann. Neurol.32, 97–100 (1992).
   PubMed Web of Science ®Google Scholar
• Krüger S, Haehner A, Thiem C, Hummel T. Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. J. Neurol.255, 1574–1579 (2008).
   PubMedGoogle Scholar
• Müller A, Reuner U, Landis B, Kitzler H, Reichmann H, Hummel T. Extrapyramidal symptoms in Wilson’s disease are associated with olfactory dysfunction. Mov. Disord.21(9), 1311–1316 (2006).
   PubMedGoogle Scholar
• Jankovic J. Parkinson’s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatr.79, 368–376 (2008).
   PubMed Web of Science ®Google Scholar
• Hoehn MM, Yahr MD. Parkinsonism. Onset, progression and mortality. Neurology17, 427–442 (1967).
   PubMed Web of Science ®Google Scholar
• Berg D. Biomarkers for the early detection of Parkinson’s and Alzheimer’s disease. Neurodegener. Dis.5, 133–136 (2008).
   PubMedGoogle Scholar
• Tolosa E, Gaig C, Santamaria J, Compta Y. Diagnosis and the premotor phase of Parkinson disease. Neurology72(Suppl. 2), 12–20 (2009).
   PubMed Web of Science ®Google Scholar